Holen Sie sich die Stockscreener-App
0.44
3.32%
-0.0151
Handel nachbörslich:
.44
Schlusskurs vom Vortag:
$0.4551
Offen:
$0.4998
24-Stunden-Volumen:
167.15K
Relative Volume:
1.04
Marktkapitalisierung:
$11.52M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-26.56M
KGV:
-0.6769
EPS:
-0.65
Netto-Cashflow:
$-22.29M
1W Leistung:
-8.14%
1M Leistung:
-15.74%
6M Leistung:
-43.95%
1J Leistung:
-87.49%
1-Tages-Spanne:
$0.4387
$0.4998
1-Wochen-Bereich:
$0.4265
$0.4998
52-Wochen-Spanne:
$0.34
$3.864
BiomX Inc Stock (PHGE) Company Profile
Firmenname
BiomX Inc
Sektor
Branche
Telefon
972 7 23942377
Adresse
7 Pinhas Sapir Street, 2nd Floor, Ness Ziona
Vergleichen Sie PHGE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PHGE
BiomX Inc
|
0.44 | 11.52M | 0 | -26.56M | -22.29M | -0.65 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.03 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
547.74 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
329.77 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
545.11 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
244.32 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
BiomX Inc Stock (PHGE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-04-15 | Eingeleitet | Ladenburg Thalmann | Buy |
BiomX Inc Aktie (PHGE) Neueste Nachrichten
BiomX Inc. Achieves Breakthrough in Treating Antibiotic-Resistant Infections - citybuzz -
BiomX Stock Could Soar 3000% As This $10M Biotech Cracks The 'Superbug' Code, Wall Street Says - FinancialContent
BiomX Highlights Progress in Phage Therapy Advancements - TipRanks
BiomX (NYSEAMERICAN:PHGE) Shares Down 4.3% – Here’s What Happened - Defense World
Biomx stock plunges to 52-week low, hitting $0.47 By Investing.com - Investing.com South Africa
Biomx stock plunges to 52-week low, hitting $0.47 - Investing.com Australia
BiomX (NYSEMKT:PHGE) Stock Price Down 32.6% – What’s Next? - Defense World
Bacteriophage Therapy Market is Booming Worldwide |Enbiotix,Micreos,BiomX - openPR.com
BiomX CEO Jonathan Solomon to Present at Biomed Israel 2025 Conf - GuruFocus
BiomX Inc. to Present Positive Phase 2 Results for BX211 at Biomed Israel 2025 Conference - Nasdaq
BiomX CEO Jonathan Solomon to Present at Biomed Israel 2025 Conference - GlobeNewswire
BiomX Breakthrough: Phase 2 Success in Fighting Antibiotic-Resistant Diabetic Foot Infections - Stock Titan
BiomX Inc. (AMEX:PHGE) Q1 2025 Earnings Call Transcript - MSN
HC Wainwright Issues Pessimistic Forecast for BiomX (NYSEAMERICAN:PHGE) Stock Price - Defense World
BiomX Inc. Earnings Call: Optimism and Progress - TipRanks
PHGE: HC Wainwright & Co. Maintains Buy Rating, Lowers Price Tar - GuruFocus
BiomX (PHGE) Price Target Reduced by Analyst Yet Buy Rating Maintained | PHGE Stock News - GuruFocus
BiomX Inc (PHGE) Q1 2025 Earnings Call Highlights: Strategic Advances and Financial Resilience - Yahoo Finance
BiomX Inc. Reports Q1 2025 Progress and Financials - TipRanks
BiomX Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
BiomX Inc. SEC 10-Q Report - TradingView
BiomX Reports First Quarter 2025 Financial Results and Provides Business and Program Updates - TradingView
BiomX Reports First Quarter 2025 Financial Results and Provides Business and Program Updates | PHGE Stock News - GuruFocus
BiomX Breakthrough: Phase 2 Trial Reveals 40% Superior Efficacy in Fighting Antibiotic-Resistant Infections - Stock Titan
BiomX (PHGE) to Release Quarterly Earnings on Thursday - Defense World
BiomX to Host First Quarter 2025 Financial Results Conference Call and Webcast on May 15, 2025 - GlobeNewswire
BiomX to Host First Quarter 2025 Financial Results Conference Call and Webcast on May 15, 2025 | PHGE Stock News - GuruFocus
BiomX Inc. to Host Conference Call for First Quarter 2025 Financial Results and Business Updates - Nasdaq
JPMorgan Chase & Co. Invests $314,000 in BiomX Inc. (NYSEMKT:PHGE) - Defense World
Short Interest in BiomX Inc. (NYSEAMERICAN:PHGE) Decreases By 48.2% - Defense World
BiomX (PHGE) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - MSN
HC Wainwright Reiterates “Buy” Rating for BiomX (NYSEMKT:PHGE) - Defense World
Q1 Earnings Estimate for BiomX Issued By HC Wainwright - Defense World
What is HC Wainwright’s Estimate for BiomX FY2025 Earnings? - Defense World
What is HC Wainwright’s Forecast for BiomX Q1 Earnings? - Defense World
HC Wainwright Issues Positive Forecast for BiomX (NYSEAMERICAN:PHGE) Stock Price - Defense World
Earnings call transcript: Biomx Q1 2025 sees potential breakthrough in phage therapy By Investing.com - Investing.com South Africa
Earnings call transcript: Biomx Q1 2025 sees potential breakthrough in phage therapy - Investing.com India
Biomx stock plunges to 52-week low, hits $0.48 - Investing.com
Biomx stock plunges to 52-week low, hits $0.48 By Investing.com - Investing.com India
BiomX Announces Compliance with NYSE Guidelines on Audit Opinion Disclosure - GlobeNewswire
BiomX stock target soars to $21 on Phase 2 trial success - Investing.com India
Finanzdaten der BiomX Inc-Aktie (PHGE)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.45%
0.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):